People · Operator
Named in public records as an officer, director or promoter · active 2006–2022 · Biotechnology, Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| MDI Therapeutics, Inc. | — | Biotechnology | Seed | $3.2M | $29.8M | 2022 |
| NanoMed Pharmaceuticals, Inc. | — | Pharmaceuticals | Seed | $3.0M | $116.0M | 2006 |
Stephen C Benoit at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Stephen C Benoit on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Patrick Morand | 1 | 5 |
| Stephen Benoit | 1 | 2 |
| Grazia C Piizzi | 1 | 1 |
| Daniel A Lawrence | 1 | 1 |
| David C Ginsburg | 1 | 1 |
| Daniel Lawrence, Ph.D. | 1 | 1 |
| Duane Day | 1 | 1 |
| Harry Ledebur, Jr. | 1 | 1 |
| Gabe Leung | 1 | 1 |
| Michael Jay | 1 | 1 |
| Douglas Morton, Jr. | 1 | 1 |
| Duane E Day | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.